'Magnetofection' delivers DNA in experimental malaria vaccine

Today's drug-delivery word of the day is "magnetofection," which essentially is the use of magnetic fields to build up a concentration of magnetic nanoparticles, each containing nucleic acids, and guide them into target cells. Michael Berger, writing in Nanowerk, discusses a particular kind of magnetic nanoparticle called the superparamagnetic iron oxide nanoparticle (SPION) that he says is emerging as a promising candidate for targeted gene delivery using magnetofection.

Berger writes about successful use of magnetofection in Australia to fight malaria. Researcher Ross Coppel and colleagues at Monash University used magnetofection to enhance delivery of a malaria DNA vaccine. They used vectors composed of SPIONs and PEI polymer.

"The procedure resulted in stable particles with a narrow size range in aqueous media, rendering them suitable for gene delivery systems," Coppel told Nanowerk. "The cellular uptake of SPIONs/PEI/DNA also increased dramatically with application of external magnetic field during the gene transfection process."

In vivo trials are now under way, Nanowerk reports.

- take a look at the story in Nanowerk
- and here's an abstract of a paper on the malaria DNA vaccine

Suggested Articles

Kala Pharma's Eysuvis on Tuesday became the first and only corticosteroid approved to treat short-term signs and symptoms of dry eye disease.

Xeris scored an FDA fast track designation for its diazepam formulation, delivered via autoinjector, to treat acute repetitive seizures.

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.